Imaging, Digital, Angiography Symposium 1

Related

• 

  Risk of Sight-Threatening Diabetic Retinopathy with GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes

  Andrew J. Barkmeier, MD

  Updates from the Field

  2024

• 

  Masked Safety Data from ZETA-1, an Ongoing 24-Week Phase 2 Clinical Trial of APX3330, an Oral Therapeutic Being Developed for the Treatment of Diabetic Retinopathy

  Michael J Allingham, MD, PhD

  Annual Meeting Talks

  2022

• 

  Treatment Effect of Intravitreal Aflibercept Injection by Baseline Factors in Moderately Severe-to-Severe NPDR in PANORAMA

  Nathan C. Steinle, MD

  Annual Meeting Talks

  2020